Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-α therapy

Rheumatology International

Volumn 29, Issue 6, 2009, Pages 651-654

  Erer, Burak ^a   Yilmaz, Gulsen ^b   Yilmaz, Fatma Meric ^b   Koklu, Seyfettin ^b  

^a Umraniye Education and Research Hospital ^*  (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Adenosine deaminase; Anti TNF ; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ADENOSINE DEAMINASE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS;

ADENOSINE DEAMINASE; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63349106979     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0750-1     Document Type: Article

References (24)

1. F Iannone VM Corrigall GH Kingsley 1994 Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis Eur J Immunol 24 2706 2713 10.1002/eji.1830241120
2. MH Weisman 2002 What are the risks of biologic therapy in rheumatoid arthritis? An update on safety J Rheumatol Suppl 65 33 38
3. MA Gardam EC Keystone R Menzies 2003 Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect Dis 3 148 155 10.1016/S1473-3099(03)00545-0
4. MB Van der Weyden WN Kelley 1976 Human adenosine deaminase distribution and properties J Biol Chem 251 5448 5456
5. M Dwivedi SP Misra V Misra 1990 Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites Am J Gastroenterol 85 1123 1125
6. OP Mishra S Yusaf Z Ali 2000 Adenosine deaminase activity and lysozyme levels in children with tuberculosis J Trop Pediatr 46 175 1788 10.1093/tropej/46.3.175
7. FC Arnett SM Edworthy DA Bloch 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302
8. Giusti G (1974) Adenosine deaminase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 1st edn. Academic Press, New York, pp 1092-1099
9. American Thoracic Society 2000 Targeted tuberculin testing and treatment of latent tuberculosis infection Am J Respir Crit Care Med 161 221 247
10. KL Winthrop 2006 Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor Nat Clin Pract Rheumatol 2 602 610 10.1038/ncprheum0336
11. J Keane S Gershon RP Wise 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 1098 1104 10.1056/NEJMoa011110
12. AK Mohan TR Coté JA Block 2004 Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor Clin Infect Dis 39 295 299 10.1086/421494
13. FDA briefing document (2003) Update on the TNF-α blocking agents. In: Safety of TNF blocking agents. http://www.fda.gov/ohrms/docket/ac03/ briefing/3930B1-01-B-TNF.Briefing.pdf. Accessed 15 September
14. A Gopi SM Madhavan SK Sharma 2007 Diagnosis and treatment of tuberculous pleural effusion in 2006 Chest 131 880 889 10.1378/chest.06-2063
15. V Lakshmi RR Rao N Joshi 1992 Serum adenosine deaminase activity in bacillary or paucibacillary pulmonary tuberculosis Indian J Pathol Microbiol 35 48 52
16. C Kelbel B Stumpf W Schmidt 1995 Role of serum adenosine deaminase as an immune parameter of tuberculosis Pneumologie 49 684 688
17. FJ Al-Shammary 1997 Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients Biochem Mol Biol Int 43 763 779
18. G Tarhan F Gumuslu N Yilmaz 2006 Serum adenosine deaminase enzyme and plasma platelet factor 4 activities in active pulmonary tuberculosis, HIV-seropositive subjects and cancer patients J Infect 52 264 268 10.1016/j.jinf.2005.06.009
19. N Kuyucu C Karakurt E Bilaloglu 1999 Adenosine deaminase in childhood pulmonary tuberculosis: diagnostic value in serum J Trop Pediatr 45 245 247 10.1093/tropej/45.4.245
20. P Miossec W van den Berg 1997 Th1/Th2 cytokine balance in arthritis Arthritis Rheum 40 2105 2115 10.1002/art.1780401203
21. RA Sari S Taysi O Yilmaz 2003 Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis Clin Exp Rheumatol 21 87 90
22. M Calis F Ates C Yazici 2005 Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behcet's disease Rheumatol Int 25 452 456 10.1007/s00296-005-0612-z
23. S Hitoglou M Hatzistilianou D Gougoustamou 2001 Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus Clin Rheumatol 20 411 416 10.1007/s100670170005
24. P Meunier P Filipe I Emerit 1995 Adenosine deaminase in progressive systemic sclerosis Acta Derm Venereol 75 297 299